Saturday 17 October 2026 Export HCA’s income statement to Excel — free account

HCA Healthcare, Inc.

HCA Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.6 billion, up 7.08% from fiscal 2024. In the quarter to June 2026, revenue grew 8.73%, EPS grew 11.6%, free cash flow fell 63.6% and total debt rose 11.8%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for ten, operating cash flow growth for three.

457.58 10.92 −2.33%

Follow HCA

Alert me

Market cap: $101.4B
P/E: 15.3×
Fwd P/E: 12.3×
Dividend yield: 0.67%
F-score: 7/9
Altman Z: 2.80
Beneish M: −2.87
Dividend safety: 78/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Insider Decisions trades per month

Total sells 31.12

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	1	—	—	5	—	—	—	—	—	—	—	—

Insider Ownership 34.40%

Capital & Financial Ratios $m

Market Cap 101,430.00

Revenue 78,013.00

Net Income 7,853.00

Free Cash Flow 5,997.00

Net Debt 48,705.00

Current Ratio 0.99

Debt/Equity (15.49)

P/E ratio 15.32

Fwd P/E 12.30

P/S ratio 1.29

P/B ratio 0.00

Past 5Y EPS Growth 20.98%

This Y EPS Growth 4.59%

Next Y EPS Growth 8.83%

Next Y revenue growth 3.87%

Next 5Y EPS Growth 7.80%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 73.57%

10-year low 10-year high

P/S against its own 10 years 78.51%

10-year low 10-year high

EV/Sales against its own 10 years 84.63%

10-year low 10-year high

EV/FCF against its own 10 years 66.25%

10-year low 10-year high

Dividends

Payout Ratio 0.10

Annual Dividend Rate 3.06

Annual Dividend Yield 0.67%

	total	individual payouts
2028	Powerpack
2027	Powerpack
2026	3.11	0.78 0.78 0.78
2025	2.88	0.72 0.72 0.72 0.72
2024	2.64	0.66 0.66 0.66 0.66
2023	2.40	0.60 0.60 0.60 0.60
2022	2.24	0.56 0.56 0.56 0.56
2021	1.92	0.48 0.48 0.48 0.48
2020	0.50	0.43 0.07
2019	1.60	0.40 0.40 0.40 0.40
2018	1.40	0.35 0.35 0.35 0.35

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	935	1,933	1,040	1,013
Receivables	9,958	10,751	10,867	12,281
Inventory	2,021	1,738	1,652	1,662
Other	2,013	1,992	2,224	2,234
	14,927	16,414	15,783	17,190

	2023	2024	2025	Q'26
Payables	4,233	4,276	4,659	4,752
ST’ Debt	2,424	4,698	4,889	6,264
Other	—	—	—	—
	12,655	15,177	16,350	17,312

Compound Annual Growth %

	10y	5y	3y
Sales	6.66%	7.97%	7.87%
Cash Flow	10.32%	6.48%	14.03%
Earnings	12.29%	12.56%	6.33%
Book Value	0.00%	0.00%	0.00%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	19,109	20,230	—	—	—
’25	18,321	18,605	19,161	19,513	75,600
’24	17,339	17,492	17,487	18,285	70,603
’23	15,591	15,861	16,213	17,303	64,968
’22	14,945	14,820	14,971	15,497	60,233
’21	13,977	14,435	15,276	15,064	58,752
’20	12,861	11,068	13,311	14,293	51,533

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	2,014	2,335	—	—	—
’25	1,651	4,210	4,416	2,359	12,636
’24	2,469	1,971	3,515	2,559	10,514
’23	1,803	2,475	2,479	2,674	9,431
’22	1,345	1,630	3,020	2,527	8,522
’21	1,988	2,251	2,277	2,443	8,959
’20	1,375	8,723	2,717	(3,583)	9,232

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	895	1,104	—	—	—
’25	660	3,034	3,128	870	7,692
’24	1,351	690	2,324	1,274	5,639
’23	606	1,234	1,332	1,515	4,687
’22	484	550	1,889	1,204	4,127
’21	1,334	1,409	1,388	1,251	5,382
’20	522	7,978	2,228	(4,331)	6,397

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	7.15	7.62	—	—	—
’25	6.45	6.83	6.96	8.14	28.33
’24	5.93	5.53	4.88	5.63	22.00
’23	4.85	4.29	3.91	5.93	18.97
’22	4.14	3.90	3.91	7.28	19.15
’21	4.14	4.36	7.00	5.75	21.16
’20	1.69	3.16	1.95	4.13	10.93

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	60.07	71.18	84.92	110.31	58.38	156.43	164.47	215.96	268.80	289.98	Analyst estimates 2026–2028 Powerpack
	High	83.69	91.03	147.42	150.17	166.87	263.92	279.02	304.86	417.14	520.00
People
People	Employees	241,000	253,000	262,000	280,000	275,000	284,000	294,000	310,000	316,000	320,000
	Revenue/emp, $m	0.17	0.17	0.18	0.18	0.19	0.21	0.20	0.21	0.22	0.24
Income, $m
Income, $m	Revenue	41,490	43,614	46,677	51,336	51,533	58,752	60,233	64,968	70,603	75,600
	Gross margin, %	83.29	83.23	83.45	83.48	83.76	83.86	84.44	84.76	84.77	84.96
	EBT	4,810	4,381	5,335	5,244	5,430	9,833	8,580	7,706	8,523	9,832
	EBT margin, %	11.59	10.04	11.43	10.22	10.54	16.74	14.24	11.86	12.07	13.01
	Net income	3,432	2,743	4,389	4,145	4,387	7,721	6,834	6,091	6,657	7,782
	Depreciation	2,000	2,162	2,309	2,626	2,751	2,880	2,998	3,112	3,347	3,567
Per share, $
Per share, $	Revenue	108.16	120.38	134.40	150.45	152.34	181.72	207.45	238.50	273.02	319.78
	Earnings	7.30	5.95	10.66	10.07	10.93	21.16	19.15	18.97	22.00	28.33
	Cash flow	14.74	14.98	19.47	22.28	27.29	27.71	29.35	34.62	40.66	53.45
	Capex	(7.20)	(8.32)	(10.29)	(12.19)	(8.38)	(11.06)	(15.14)	(17.42)	(18.85)	(20.91)
	Free cash flow	7.54	6.65	9.18	10.09	18.91	16.65	14.21	17.21	21.81	32.54
	Book value	(14.68)	(13.79)	(8.40)	(1.66)	8.55	4.61	(0.25)	3.89	2.15	(11.72)
	Shares, m	384	362	347	341	338	323	290	272	259	236
Valuation, ×
Valuation, ×	P/E	10.17	15.07	11.69	14.68	15.05	12.09	12.65	14.51	13.66	16.45
	P/S	0.69	0.74	0.93	0.98	1.08	1.41	1.17	1.15	1.10	1.46
	P/B	0.00	0.00	0.00	0.00	19.24	55.79	0.00	70.75	139.86	0.00
	EV/Sales	1.43	1.48	1.62	1.63	1.65	1.98	1.79	1.75	1.68	2.06
	EV/FCF	20.50	26.86	23.70	24.26	13.26	21.59	26.12	24.25	21.05	20.26
Cash, $m
Cash, $m	Operating cash flow	5,653	5,426	6,761	7,602	9,232	8,959	8,522	9,431	10,514	12,636
	Capex	(2,760)	(3,015)	(3,573)	(4,158)	(2,835)	(3,577)	(4,395)	(4,744)	(4,875)	(4,944)
	Free cash flow	2,893	2,411	3,188	3,444	6,397	5,382	4,127	4,687	5,639	7,692
Balance, $m
Balance, $m	Working capital	3,252	3,819	2,644	3,439	3,629	3,960	3,741	2,272	1,237	(567)
	Total debt	31,376	33,058	32,821	33,722	31,004	34,579	38,084	39,593	43,031	46,492
	Net debt	30,730	32,326	32,319	33,101	29,211	33,128	37,176	38,658	41,098	45,452
	Shareholders’ equity	(5,633)	(4,995)	(2,918)	(565)	2,892	1,489	(73)	1,060	555	(2,771)
Returns, %
Returns, %	ROA	8.69	6.30	9.99	8.32	8.11	14.16	10.94	9.65	9.95	11.28
	ROIC	15.57	13.95	14.18	13.95	14.24	17.68	15.33	15.18	15.86	17.64
	ROE	(49.49)	(41.70)	(95.72)	(201.26)	322.65	317.55	797.03	1,062.21	713.31	(612.27)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
HCA HCA Healthcare, Inc.	$101.4B	15.3×	12.3×	+8.73% (above 0%: growing)	+11.57% (above 0%: growing)	−63.61% (below 0%: shrinking)	85.73%	15.24%
THC Tenet Healthcare Corporation	$22.2B	10.3×	6.4×	+14.61% (above 0%: growing)	+212.97% (above 0%: growing)	−43.88% (below 0%: shrinking)	46.78%	24.85%	Compare
EHC Encompass Health Corporation	$12.6B	20.6×	16.8×	+9.58% (above 0%: growing)	+9.93% (above 0%: growing)	−45.01% (below 0%: shrinking)	100.00%	17.85%	Compare
DVA DaVita Inc.	$12.1B	15.0×	13.1×	+5.17% (above 0%: growing)	+56.49% (above 0%: growing)	+49.36% (above 0%: growing)	32.70%	16.29%	Compare
FMS Fresenius Medical Care AG & Co. KGaA	$11.8B	11.5×	12.5×	+3.89% (above 0%: growing)	+6.82% (above 0%: growing)	+1.57% (above 0%: growing)	26.95%	9.58%	Compare
UHS Universal Health Services, Inc.	$11.0B	7.5×	6.1×	+8.27% (above 0%: growing)	+9.47% (above 0%: growing)	−23.78% (below 0%: shrinking)	90.87%	11.14%	Compare
ENSG The Ensign Group, Inc.	$10.4B	26.9×	24.1×	+17.33% (above 0%: growing)	+16.22% (above 0%: growing)	+12.24% (above 0%: growing)	16.65%	8.50%	Compare
PACS PACS Group, Inc.	$7.6B	27.6×	16.8×	+9.07% (above 0%: growing)	+45.45% (above 0%: growing)	+220.51% (above 0%: growing)	17.07%	7.66%	Compare
CHE Chemed Corporation	$6.7B	25.7×	20.4×	+8.80% (above 0%: growing)	+42.78% (above 0%: growing)	−43.51% (below 0%: shrinking)	32.90%	13.25%	Compare
Median of peers	$11.4B	17.8×	15.0×	+8.94%	+29.50%	−11.11%	32.80%	12.20%

All 55 Medical Care Facilities stocks →

HCA Healthcare, Inc. (HCA) key facts

Strength: HCA Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.6 billion, up 7.08% from fiscal 2024.
Strength: Net income was $7.8 billion, or $28.33 per share (basic), a net margin of 8.97%.
HCA Healthcare, Inc. (HCA) is a Medical Care Facilities company in the Healthcare sector, listed on the New York Stock Exchange.
As of October 16, 2026, HCA traded at $457.58, a market capitalization of $101.4 billion.
At that price the stock trades at 15.3× trailing-twelve-month earnings and 1.3× sales; its P/E is higher than 74% of its own readings over the past ten years.
HCA Healthcare, Inc. pays an annual dividend of $3.06 per share, a yield of 0.67%, with a payout ratio of 10.2%.
Return on equity was −612.3% and debt-to-equity -15.49.
Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 2.80 (grey zone) for fiscal 2025.